Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 7Recruiting 5Unknown 3Active not recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 1

Conditions

Pancreatic Neoplasms 4Peritoneal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Locally Advanced Pancreatic Cancer 1Gastroparesis 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Pancreatectomy × Clear all
NCT07493421 2026-03-25

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Unidade Local de Saúde São João

Phase NA Recruiting
20 enrolled
GastrointestinalGynecologic

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms

NCT07396662 2026-02-09

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

National Taiwan University Hospital

Recruiting
3,500 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07382791 2026-02-03

Delayed Gastric Emptying After Pancreatic Surgery

National Taiwan University Hospital

Recruiting
3,500 enrolled
Gastrointestinal

Pancreatic Neoplasms, Gastroparesis

NCT06944587 2025-04-25

NORPACT-3

Oslo University Hospital

Recruiting
400 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡